Journal Of Bone And Joint Infection

metrics 2024

Driving collaboration for improved patient outcomes.

Introduction

Journal of Bone and Joint Infection, published by COPERNICUS GESELLSCHAFT MBH, is a pioneering open-access journal dedicated to the multidisciplinary field of bone and joint infections. Since its inception in 2016, it has served as a vital platform for researchers and practitioners to share cutting-edge findings, clinical practices, and innovative research methodologies from around the globe. Based in Germany, this journal has quickly established itself with a significant impact, currently holding a Q3 placement in Infectious Diseases and Q2 in both Orthopedics & Sports Medicine and Surgery, alongside commendable Scopus rankings. With the aim of advancing knowledge and fostering collaboration in the treatment and understanding of osteoarticular infections, the journal invites submissions that contribute to the scientific community's quest for effective management strategies and improved patient outcomes. The open-access format ensures that groundbreaking research is readily accessible, promoting wider dissemination and visibility within the community. As the Journal of Bone and Joint Infection continues through its converged years (2016-2024), it remains committed to supporting ongoing education and innovation in this critical area of medical research.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor1.80
Journal Impact Factor (5 years)-
H-Index-
Journal IF Without Self1.80
Eigen Factor0.00
Normal Eigen Factor-
Influence-
Immediacy Index1.20
Cited Half Life4.30
Citing Half Life7.50
JCI0.63
Total Documents-
WOS Total Citations595
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

INFECTIOUS DISEASES
Rank 94/132
Percentile 29.20
Quartile Q3
ORTHOPEDICS
Rank 61/136
Percentile 55.50
Quartile Q2
SURGERY
Rank 123/290
Percentile 57.80
Quartile Q2

JCI (Web Of Science)

INFECTIOUS DISEASES
Rank 62/132
Percentile 53.03
Quartile Q2
ORTHOPEDICS
Rank 82/136
Percentile 39.71
Quartile Q3
SURGERY
Rank 151/290
Percentile 47.93
Quartile Q3

Quartile History

Similar Journals

Frontiers in Cellular and Infection Microbiology

Exploring innovative solutions in cellular and infection microbiology.
Publisher: FRONTIERS MEDIA SAISSN: 2235-2988Frequency: 1 issue/year

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

Medical Mycology Journal

Elevating Understanding of Fungal Infections Worldwide
Publisher: JAPANESE SOC MEDICAL MYCOLOGYISSN: 2185-6486Frequency: 4 issues/year

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

Arthroplasty Today

Advancing orthopedic knowledge for a healthier tomorrow.
Publisher: ELSEVIERISSN: 2352-3441Frequency: 6 issues/year

Arthroplasty Today is a distinguished journal published by Elsevier that has been at the forefront of orthopedic research since its launch in 2015. With a commitment to open access, the journal provides a platform for disseminating high-quality research in both the Orthopedics and Sports Medicine fields and Surgery, holding respectable positions in Scopus rankings with an impressive Q1 and Q2 quartile status. The journal aims to foster collaboration and innovation among researchers, healthcare professionals, and students by publishing cutting-edge studies, clinical outcomes, and advancements in arthroplasty techniques. Operating out of the United States, Arthroplasty Today not only enhances visibility for its contributors but also enriches the global discourse on orthopedic procedures, catering to a diverse audience eager to stay informed of the latest findings and methodologies. Access to this wealth of information is unrestricted, ensuring that relevant knowledge is available to all stakeholders in the medical community.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Connecting Science and Practice in Microbiology
Publisher: ELSEVIER SCIENCE INCISSN: 0732-8893Frequency: 12 issues/year

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

Urologia Journal

Empowering Clinicians with Cutting-edge Research.
Publisher: SAGE PUBLICATIONS LTDISSN: 0391-5603Frequency: 4 issues/year

Urologia Journal, with ISSN 0391-5603 and E-ISSN 1724-6075, is a pivotal publication in the field of urology, published by SAGE Publications Ltd. Established in the United States, the journal has a rich historical foundation, with coverage spanning various periods beginning in 1947 and continuing to the present day, indicating its commitment to chronicling advancements in urological research and practice. As of 2023, the journal has achieved a respectable Q3 ranking in the field of Urology, reflecting its increasing influence and relevance among academic peers. Though not an open-access journal, it provides substantial value to its readers with rigorous peer-reviewed content that enhances the understanding and treatment of urological conditions. Researchers, clinicians, and students are encouraged to engage with the Urologia Journal to keep abreast of the latest findings and methodologies that contribute to better patient care and innovative therapeutic options in urology. As the field evolves, Urologia Journal remains committed to promoting quality scholarship and disseminating vital knowledge that shapes the future of urology.

ORTHOPEDIC CLINICS OF NORTH AMERICA

Empowering professionals with cutting-edge insights in orthopedics.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0030-5898Frequency: 4 issues/year

ORTHOPEDIC CLINICS OF NORTH AMERICA, published by W B Saunders Co-Elsevier Inc., is a leading peer-reviewed journal in the field of orthopedics and sports medicine, established in 1970 and continuing to be influential through 2024. With an ISSN of 0030-5898 and an E-ISSN of 1558-1373, it is recognized for its rigorous academic standards, achieving a Q2 ranking in the 2023 Scopus category for orthopedics and sports medicine, placing it in the 67th percentile among its peers. This journal provides a comprehensive range of scholarly articles, clinical studies, and reviews designed to advance orthopedic knowledge and enhance patient care. While the journal currently does not offer open access options, it remains accessible to professionals, researchers, and students who seek to stay updated with the latest advancements and trends in orthopedics. By disseminating critical research findings and clinical insights, ORTHOPEDIC CLINICS OF NORTH AMERICA plays a vital role in shaping the future of orthopedic practice and education.

Therapeutic Advances in Infectious Disease

Connecting research and practice for better patient outcomes.
Publisher: SAGE PUBLICATIONS LTDISSN: 2049-9361Frequency: 6 issues/year

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Annals of Joint

Shaping the Future of Joint Health and Sports Performance.
Publisher: AME PUBLISHING COMPANYISSN: 2415-6809Frequency: 12 issues/year

Annals of Joint, published by the renowned AME Publishing Company in China, is a pivotal open-access journal dedicated to advancing the fields of Orthopedics and Sports Medicine. With an ISSN of 2415-6809 and a commendable ranking as Q3 in its category for 2023, the journal seeks to engage a diverse audience of researchers, healthcare professionals, and students through its comprehensive coverage of innovative research, clinical practices, and emerging trends within the field. Spanning the converged years from 2019 to 2024, the journal aims to foster knowledge dissemination and collaboration amongst scholars and practitioners alike while maintaining a focus on the practical applications of orthopedic and sports medicine research. Published in Hong Kong, the journal represents a crucial platform for sharing ideas and advancing scholarly discourse, as it addresses the ever-evolving challenges in orthopedics.

Lancet Microbe

Fostering Collaboration for a Healthier Tomorrow
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

Annals of Clinical Microbiology and Antimicrobials

Exploring the forefront of clinical microbiology and antimicrobials.
Publisher: BMCISSN: Frequency: 1 issue/year

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.